NodeAI (Decision/Risk Analysis) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

NodeAI (Decision/Risk Analysis) General Information

Description

Developer of a diagnostic platform designed to enhance lung cancer staging accuracy. The company's platform integrates artificial intelligence, machine learning, ultrasound image analysis, and automated report generation for lymph node detection and malignancy prediction, enabling healthcare professionals to improve diagnostic precision, reduce repeat biopsies, and streamline clinical workflows for better patient outcomes.

Contact Information

Website
www.nodeai.ca
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 175 Longwood Road South number 113
  • Hamilton, Ontario L8P 0A1
  • Canada
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 175 Longwood Road South number 113
  • Hamilton, Ontario L8P 0A1
  • Canada

NodeAI (Decision/Risk Analysis) Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NodeAI (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 23-Oct-2025 Completed Generating Revenue
2. Angel (individual) 01-Oct-2025 Completed Generating Revenue
1. Grant 25-Mar-2025 $100K Completed Generating Revenue
To view NodeAI (Decision/Risk Analysis)’s complete valuation and funding history, request access »

NodeAI (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NodeAI (Decision/Risk Analysis) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital
HaloHealth Angel Group Minority
FACIT Venture Capital Minority
To view NodeAI (Decision/Risk Analysis)’s complete investors history, request access »

Ready to get started?

Request a free trial

NodeAI (Decision/Risk Analysis) FAQs

  • When was NodeAI (Decision/Risk Analysis) founded?

    NodeAI (Decision/Risk Analysis) was founded in 2023.

  • Where is NodeAI (Decision/Risk Analysis) headquartered?

    NodeAI (Decision/Risk Analysis) is headquartered in Hamilton, Canada.

  • What is the size of NodeAI (Decision/Risk Analysis)?

    NodeAI (Decision/Risk Analysis) has 4 total employees.

  • What industry is NodeAI (Decision/Risk Analysis) in?

    NodeAI (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is NodeAI (Decision/Risk Analysis) a private or public company?

    NodeAI (Decision/Risk Analysis) is a Private company.

  • What is NodeAI (Decision/Risk Analysis)’s current revenue?

    The current revenue for NodeAI (Decision/Risk Analysis) is .

  • Who are NodeAI (Decision/Risk Analysis)’s investors?

    Ontario Bioscience Innovation Organization, HaloHealth, and FACIT have invested in NodeAI (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process